Edition:
United Kingdom

Boule Diagnostics AB (BOUL.ST)

BOUL.ST on Stockholm Stock Exchange

96.97SEK
25 Sep 2018
Change (% chg)

7.37kr (+8.23%)
Prev Close
89.60kr
Open
90.07kr
Day's High
97.99kr
Day's Low
89.97kr
Volume
8,748
Avg. Vol
22,369
52-wk High
108.88kr
52-wk Low
60.88kr

Summary

Name Age Since Current Position

Peter von Ehrenheim

62 2016 Independent Chairman of the Board

Fredrik Dalborg

46 2017 President, Chief Executive Officer

Christina Rubenhag

2017 Chief Financial Officer, Senior Vice President

Fredrik Ekdahl

2017 Senior Vice President Research & Development

Michael Elliott

64 Senior Vice President Research & Development at CDS

Debbie Herrera

2017 Senior Vice President of Quality & Regulatory

Hans Johansson

50 Senior Vice President of Production

Kiarash Farr

2018 Director of Commercial Operations

Thomas Eklund

51 2014 Director

Charlotta Falvin

52 2018 Director

Karin Dahllof

58 2015 Independent Director

Jon Risfelt

57 2016 Independent Director

Biographies

Name Description

Peter von Ehrenheim

Mr. Peter von Ehrenheim has served as Independent Chairman of the Board of Directors of Boule Diagnostics AB since January 25, 2016. He has been Independent Director of the Company since May 12, 2015. He also serves as Chairman of the Board of Biolin Scientific Holding AB and Robustus Wear Components AB, as well as Member of the Board of Nanologica AB and Biotage AB. And deputy at VBN Components AB. He is Entrepreneur. He holds a Master of Science degree in Engineering from Kungliga Tekniska Hogskolan - KTH.

Fredrik Dalborg

Mr. Fredrik Dalborg has been appointed President and Chief Executive Officer at Boule Diagnostics AB effective as of April 1, 2017. He was recently Vice President with responsibility for business area Therapeutic Systems at Terumo BCT. He has worked for almost 14 years in global marketing for medtech industry. He holds Master of Science from Stockholm School of Economics and is reserve officer in Swedish Navy.

Christina Rubenhag

Ms. Christina Rubenhag has been appointed Chief Financial Officer and Senior Vice President at Boule Diagnostics AB effective as of October 9, 2017. She was recently CEO of Biolin Scientific Holding AB. Before that, she served as CFO of Biolin Scientific Holding AB, Packetfront AB and Swe-Dish Satellite Systems AB. Christina holds Bachelor of Science degree in Economics and Business Administration from Handelshogskolan i Umea.

Fredrik Ekdahl

Mr. Fredrik Ekdahl has been Senior Vice President Research & Development at Boule Diagnostics AB since June 1, 2017. He has been employed since 2012. He holds Bachelor of Science in Mechanical Engineering from the Institute of Technology of Linkoping University.

Michael Elliott

Mr. Michael Elliott serves as Senior Vice President Research & Development at CDS within Boule Diagnostics AB. He was previously Head of Development for Reagents. He has been employed at CDS since 2000. He holds a Master of Science degree in Natural Science from Queens University of Belfast and an Executive Master of Business Administration degree from Florida Atlantic University.

Debbie Herrera

Ms. Debbie Herrera has been Senior Vice President of Quality & Regulatory at Boule Diagnostics AB since June 1, 2017. She has been employed since early 2017. She holds Master of Science Organization and Management, Capella University, Bachelor of Science, Microbiology, Florida Atlantic University, Bachelor of Arts, Chemistry, Florida Atlantic University.

Hans Johansson

Mr. Hans Johansson serves as Senior Vice President of Production at Boule Diagnostics AB. He served as Chief Executive Officer of Boule Medical (Beijing) within Boule Diagnostics AB until 2011. He was also Head of Production in Boule Medical. He has been employed at the Company since 2001. He holds Master of Science in Applied Physics and Electrical Engineering, and a Licentiate of Engineering in Material Physics, both from the Institute of Technology of Linkoping University.

Kiarash Farr

Mr. Kiarash Farr has been appointed Director of Commercial Operations at Boule Diagnostics AB effective as of March 1, 2018. He previously was Head of Commercial Operations EMEA at Hycor Biomedical LLC. Before that, he worked as Sales Director Key Account at Thermo Fisher Scientific, Global Sales Director, Director of Global Business Development and Sales Director Asia Pacific at IBA, Sales Manager at Scanditronix Wellhofer, as well as Product Development Manager at Scanditronix Medical. He is Civil Engineer in Engineering Physics from Kungliga Tekniska Hogskolan. He has also studied Medical Engineering at Karolinska University Hospital and management at INSEAD in France.

Thomas Eklund

Mr. Thomas Eklund has been Member of the Board of Directors at Boule Diagnostics AB since May 13, 2014. He is also Chairman of Itrim AB, Moberg Pharma AB and Sedana Medical AB as well as board member of Memira AB, Biotage AB and Rodebjer Form AB. He is also Advisor and Consultant. He holds Master of Business Administration degree from Stockholm School of Economics.

Charlotta Falvin

Karin Dahllof

Ms. Karin Dahllof has served as Independent Member of the Board of Directors at Boule Diagnostics AB since May 12, 2015. She also serves as Director Special Projects at HemoCue AB. She is educated as biomedical analyst from the University of Gothenburg.

Jon Risfelt

Mr. Jon Risfelt has been Independent Director of Boule Diagnostics AB since May 12, 2016. He is also Chairman of Bisnode AB, Ixat Intressenter AB (Cabonline) and Smartfish AS, as well as Board Member in Bilia AB, Dialect AB and Knowit AB, among others. He is Advisor and Consultant. He holds Master of Science in Chemistry Technique from the Royal Institute of Technology.